Form 4 holding
Director
RIGEL PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 18,250
- Estimated value
- $493,480
- Report date
- 15 May 2026
- Price
- $27.04
- Ownership
- Direct
Jane Wasman - Director at RIGEL PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- RIGL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jane Wasman since 20 Sep 2025
Reported holdings for Jane Wasman in RIGEL PHARMACEUTICALS INC
Form 4 holding
Director
RIGEL PHARMACEUTICALS INC
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 3,000
- Estimated value
- Report date
- 23 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jane Wasman in RIGEL PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.